# Brian Kobilka > American physiologist **Wikidata**: [Q80907](https://www.wikidata.org/wiki/Q80907) **Wikipedia**: [English](https://en.wikipedia.org/wiki/Brian_Kobilka) **Source**: https://4ort.xyz/entity/brian-kobilka ## Summary Brian Kobilka, born May 30, 1955, in Little Falls [1][2], is a United States citizen whose career spans multiple scientific disciplines. He works as a biochemist, physicist, university teacher, chemist, physiologist, and crystallographer . A practicing Catholic [3], Kobilka earned his education at the University of Minnesota Duluth, Yale School of Medicine, and Duke University .Kobilka has been affiliated with Duke University and Stanford University School of Medicine, and has served at Stanford University since 1989 [4]. His primary field of study is crystallography . His contributions to science have been recognized with several awards, including the Nobel Prize in Chemistry, John J. Abel Award, Mendel Medal, The Louis and Artur Lucian Award in Cardiovascular Diseases, and Julius Axelrod Award [5][6][7][8][9]. ## Summary Brian Kobilka is an American physiologist known for his groundbreaking research in G protein-coupled receptors (GPCRs), particularly the discovery of their three-dimensional structure. His work has revolutionized drug development and our understanding of cellular signaling pathways. ## Biography - Born: May 30, 1955 - Nationality: United States - Education: - Bachelor of Science in Chemistry, University of Minnesota Duluth (1977) - Doctor of Philosophy in Biochemistry, Yale School of Medicine (1981) - Known for: Pioneering the structural analysis of G protein-coupled receptors - Employer(s): - Duke University (1981–present) - National Academy of Sciences (member) - American Academy of Arts and Sciences (member) - Field(s): Physiology, Biochemistry, Crystallography ## Contributions - **Structural Analysis of GPCRs**: Kobilka and colleagues determined the three-dimensional structure of rhodopsin, the first G protein-coupled receptor, using X-ray crystallography. This breakthrough provided a foundation for understanding how drugs interact with these receptors. - **Nobel Prize in Chemistry**: Awarded in 2012 for his work on GPCRs, specifically for "studying G protein-coupled receptors." - **Key Publications**: Authored numerous influential papers on GPCR structure and function, including seminal works in *Nature* and *Science*. - **Awards and Recognition**: - Nobel Prize in Chemistry (2012) - John J. Abel Award (1991) - Julius Axelrod Award (1991) - Mendel Medal (2002) - The Louis and Artur Lucian Award in Cardiovascular Diseases (2008) ## FAQs **What is Brian Kobilka known for?** Brian Kobilka is renowned for his pioneering work in determining the three-dimensional structure of G protein-coupled receptors (GPCRs), particularly rhodopsin, which revolutionized drug development and cellular signaling research. **Where did Brian Kobilka study?** Kobilka earned his Bachelor of Science in Chemistry from the University of Minnesota Duluth in 1977 and his Doctor of Philosophy in Biochemistry from Yale School of Medicine in 1981. **What awards has Brian Kobilka received?** He has received numerous prestigious awards, including the Nobel Prize in Chemistry (2012), the John J. Abel Award (1991), the Julius Axelrod Award (1991), the Mendel Medal (2002), and the Louis and Artur Lucian Award in Cardiovascular Diseases (2008). **Where has Brian Kobilka worked?** Kobilka has been affiliated with Duke University since 1981 and is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. **What is the significance of Brian Kobilka's work?** His research on GPCRs has provided critical insights into cellular signaling pathways, enabling the development of targeted therapies for diseases like cancer, diabetes, and cardiovascular disorders. ## Why They Matter Brian Kobilka's work on GPCRs has had a profound impact on medicine and biochemistry. By determining the structure of rhodopsin, he laid the groundwork for understanding how drugs interact with these receptors, leading to the development of more effective treatments. His research has influenced drug discovery, cellular biology, and our understanding of how cells communicate. Kobilka's contributions have shaped modern pharmacology and continue to guide scientific advancements in the field. ## Notable For - **Nobel Prize in Chemistry (2012)**: Awarded for his work on G protein-coupled receptors. - **Structural Analysis of Rhodopsin**: First to determine the three-dimensional structure of a GPCR, revolutionizing drug development. - **Key Contributor to Crystallography**: Pioneered the use of X-ray crystallography in studying GPCRs. - **Member of Prestigious Academies**: National Academy of Sciences and American Academy of Arts and Sciences. - **Influential Publications**: Authored seminal works in *Nature* and *Science* on GPCR structure and function. - **Awards in Pharmacology and Cardiovascular Research**: Recognized for his contributions to pharmacology and cardiovascular diseases. ## Body ### Early Life and Education Brian Kobilka was born on May 30, 1955, in the United States. He pursued his undergraduate studies in chemistry at the University of Minnesota Duluth, graduating in 1977. He then earned his Doctor of Philosophy in Biochemistry from Yale School of Medicine in 1981, where he began his research career. ### Career and Research Focus Kobilka's career has been centered at Duke University, where he has been affiliated since 1981. His primary focus has been on G protein-coupled receptors (GPCRs), a class of membrane proteins that regulate cellular responses to various stimuli. His most significant contribution was the determination of the three-dimensional structure of rhodopsin, the first GPCR, using X-ray crystallography. This breakthrough provided a foundation for understanding how drugs interact with these receptors and has had a profound impact on drug development. ### Key Discoveries and Publications Kobilka's research on GPCRs has led to numerous influential publications. His work on the structure of rhodopsin was published in *Nature* and *Science*, among other high-impact journals. These publications have been cited extensively and have shaped the field of pharmacology. His discoveries have enabled the development of targeted therapies for diseases such as cancer, diabetes, and cardiovascular disorders. ### Awards and Recognition Kobilka's contributions have been recognized with numerous prestigious awards, including the Nobel Prize in Chemistry in 2012. He has also received the John J. Abel Award (1991), the Julius Axelrod Award (1991), the Mendel Medal (2002), and the Louis and Artur Lucian Award in Cardiovascular Diseases (2008). These awards highlight his significant impact on the fields of pharmacology and biochemistry. ### Professional Affiliations Kobilka is a member of the National Academy of Sciences and the American Academy of Arts and Sciences, reflecting his status as a leading figure in the scientific community. His affiliations with these prestigious organizations underscore his influence and contributions to the field. ### Legacy and Influence Brian Kobilka's work on GPCRs has had a lasting impact on medicine and biochemistry. His research has provided critical insights into cellular signaling pathways, enabling the development of more effective treatments for various diseases. His contributions continue to guide scientific advancements and have influenced drug discovery and cellular biology. Kobilka's legacy is marked by his pioneering work and the recognition he has received for his groundbreaking research. ## References 1. [ORCID Public Data File 2020](https://pub.orcid.org/v3.0_rc1/0000-0001-5958-3990/employment/9210496) 2. [Catholic scientist at Stanford shares Nobel Prize for work in chemistry. 2013](https://www.catholicnews.com/services/englishnews/2012/catholic-scientist-at-stanford-shares-nobel-prize-for-work-in-chemistry.cfm) 3. [The Nobel Prize in Chemistry 2012. nobelprize.org](https://www.nobelprize.org/prizes/chemistry/2012/summary/) 4. [Table showing prize amounts. Nobel Foundation](https://www.nobelprize.org/uploads/2019/04/prize-amounts-2020.pdf) 5. [Source](https://www.aspet.org/aspet/meetings-awards/aspet-awards/aspet-scientific-achievement-awards/john-j-abel-award) 6. [Source](https://www1.villanova.edu/villanova/president/university_events/mendelmedal/pastrecipients/brian_kobilka.html) 7. [Source](https://www.aspet.org/aspet/meetings-awards/aspet-awards/aspet-scientific-achievement-awards/aspet-award-winners/2010-aspet-award-winners) 8. Virtual International Authority File 9. Encyclopædia Britannica Online 10. Munzinger Personen 11. Freebase Data Dumps. 2013 12. YouTube 13. [Source](http://www.nasonline.org/member-directory/living-member-list.html)